Cookies on the Economic Times website

Economic Times has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings,we'll assume that you are happy to receive all cookies on the Economic Times website. However, you can change your cookie setting at any time by clicking on our Cookie Settings at any time.You can also see our Privacy Policy

Ahead of Covid vaccine, government & companies stock up vials, syringes


Since most companies would trade through government institutions and not the private market, they are going for multi-dose vials which will bring down the number of units required.


To meet that demand, pharma companies, which are working on the potential vaccine candidate for Covid-19, have started tying up with manufacturers of vials and the rubber stoppers that are used in the vials.

The government and pharma companies have started stockpiling syringes and vials, as they begin the groundwork for a rapid, safe and efficient delivery of potential vaccines.“Scaling up the manufacturing of syringes and other medical products required to deliver a vaccine to the Indian population will be just as important as the vaccine itself,” said a senior government official. Around 300 million people are likely to receive the first shot of

To Read the Full Story, Become an ET Prime Member

Access the exclusive Economic Times stories, Editorial and Expert opinion


  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise